Literature DB >> 425912

Platelet function studies in coronary artery disease. V. Evidence for enhanced platelet microthrombus formation activity in acute myocardial infarction.

P Mehta, J Mehta.   

Abstract

Circulating platelet microthrombi were evaluated during the acute and convalescent phases of illness in 44 patients admitted to the hospital for chest pain. Similar studies were performed in 10 healthy volunteers and 6 patients with infection. Circulating platelet microthrombi were significantly increased during the acute phase in 22 patients with transmural myocardial infarction compared with values in the other 22 patients without myocardial infarction, the healthy volunteers and the patients with infection alone. This increase in circulating platelet microthrombi declined to normal levels by the 7th hospital day in all but two patients who had evidence of extension of myocardial infarction and died. In contrast, circulating platelet microthrombi were similar in acute and convalescent phases of patients with chest pain but without myocardial infarction and were comparable with values in healthy volunteers. This study suggests that increased circulating platelet microthrombi may be related to tissue necrosis associated with transmural myocardial infarction.

Entities:  

Mesh:

Year:  1979        PMID: 425912     DOI: 10.1016/0002-9149(79)90075-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  12 in total

1.  Isosorbide dinitrate inhibits platelet adhesion and aggregation in nonthrombolyzed patients with acute myocardial infarction.

Authors:  J Gebalska; R Wolk; L Ceremuzynski
Journal:  Clin Cardiol       Date:  2000-11       Impact factor: 2.882

2.  Effects of the PAF antagonists BN50726 and BN50739 on arrhythmogenesis and extent of necrosis during myocardial ischaemia/reperfusion in rabbits.

Authors:  S Chakrabarty; D S Fluck; N A Flores; D J Sheridan
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

3.  Electrophysiological and arrhythmogenic effects of platelet activating factor during normal perfusion, myocardial ischaemia and reperfusion in the guinea-pig.

Authors:  N A Flores; D J Sheridan
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

4.  Coronary thrombosis and platelet/fibrin microemboli in death associated with acute myocardial infarction.

Authors:  R J Frink; P A Rooney; J O Trowbridge; J P Rose
Journal:  Br Heart J       Date:  1988-02

5.  Platelet size in myocardial infarction.

Authors:  H A Cameron; R Phillips; R M Ibbotson; P H Carson
Journal:  Br Med J (Clin Res Ed)       Date:  1983-08-13

6.  Relationships of the platelet aggregate ratio to serum cholesterol concentration, smoking and age.

Authors:  J W Davis; P E Phillips; H D Lewis; R F Davis
Journal:  Postgrad Med J       Date:  1981-03       Impact factor: 2.401

7.  Effects of atrioventricular asynchrony on platelet activation: implication of thromboembolism in paced patients.

Authors:  C P Lau; H F Tse; G Cheng
Journal:  Heart       Date:  1997-10       Impact factor: 5.994

8.  Arachidonic acid metabolites, hypertension and arteriosclerosis.

Authors:  P C Weber; W Siess; B Scherer; E Held; H Witzgall; R Lorenz
Journal:  Klin Wochenschr       Date:  1982-05-17

9.  Metoprolol does not reduce platelet aggregability during sympatho-adrenal stimulation.

Authors:  P T Larsson; G Olsson; B Angelin; E Granström; G Hansson; P Hjemdahl
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

10.  Effect of long-term beta-blockade with alprenolol on platelet function and fibrinolytic activity in patients with coronary heart disease.

Authors:  H J Jürgensen; J Dalsgaard-Nielsen; E Kjøller; J Gormsen
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.